TY - JOUR
T1 - Non-hormonal treatment of vulvo-vaginal atrophy-related symptoms in post-menopausal women
AU - Tersigni, C.
AU - Di Simone, Nicoletta
AU - Tempestilli, E.
AU - Cianfrini, F.
AU - Russo, R.
AU - Moruzzi, M. C.
AU - Amar, I. D.
AU - Fiorelli, A.
AU - Scambia, Giovanni
AU - Villa, Paola
PY - 2015
Y1 - 2015
N2 - In post-menopausal period vulvo-vaginal atrophy (VVA)-related symptoms may seriously affect women's quality of life. Hormonal replacement therapy effectively relieves these symptoms but it is not always safe or accepted, and a non-hormonal treatment is often needed instead. Over a period of 12 weeks, we tested the effect of a twice-a-week vulvo-vaginal application of a hyaluronic acid, AC collagen, isoflavones and vitamins-based cream (Perilei Pausa(®)) on 35 women in post-menopausal period, reporting VVA-related symptoms. After 12 weeks of treatment with Perilei Pausa(®) a significant improvement in vaginal dryness, vulvo-vaginal itching, dyspareunia (P < 0.001), dysuria (P = 0.02), nocturia (P = 0.009) and pollakiuria (P = 0.005) was reported by the women. Colposcopical score assessing the intensity of atrophic colpitis, cervico-vaginal paleness and petechiae was also reduced (P = 0.037, P = 0.016 and P = 0.032, respectively). No significant difference in terms of maturation value of cervico-vaginal epithelium was observed. In conclusion, Perilei Pausa(®) may represent an effective and safe alternative treatment of symptomatic VVA in post-menopausal women.
AB - In post-menopausal period vulvo-vaginal atrophy (VVA)-related symptoms may seriously affect women's quality of life. Hormonal replacement therapy effectively relieves these symptoms but it is not always safe or accepted, and a non-hormonal treatment is often needed instead. Over a period of 12 weeks, we tested the effect of a twice-a-week vulvo-vaginal application of a hyaluronic acid, AC collagen, isoflavones and vitamins-based cream (Perilei Pausa(®)) on 35 women in post-menopausal period, reporting VVA-related symptoms. After 12 weeks of treatment with Perilei Pausa(®) a significant improvement in vaginal dryness, vulvo-vaginal itching, dyspareunia (P < 0.001), dysuria (P = 0.02), nocturia (P = 0.009) and pollakiuria (P = 0.005) was reported by the women. Colposcopical score assessing the intensity of atrophic colpitis, cervico-vaginal paleness and petechiae was also reduced (P = 0.037, P = 0.016 and P = 0.032, respectively). No significant difference in terms of maturation value of cervico-vaginal epithelium was observed. In conclusion, Perilei Pausa(®) may represent an effective and safe alternative treatment of symptomatic VVA in post-menopausal women.
KW - post-menopausal women
KW - vulvo-vaginal atrophy
KW - post-menopausal women
KW - vulvo-vaginal atrophy
UR - http://hdl.handle.net/10807/70317
U2 - 10.3109/01443615.2015.1014326
DO - 10.3109/01443615.2015.1014326
M3 - Article
SN - 0144-3615
VL - 35
SP - 835
EP - 838
JO - Journal of Obstetrics and Gynaecology
JF - Journal of Obstetrics and Gynaecology
ER -